secwatch.observer — SEC 8-K summary
======================================

Issuer:     MetaVia Inc. (MTVA)
CIK:        0001638287
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001558370-23-016982
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NeuroBo Pharmaceuticals appoints Marshall H. Woodworth as Acting CFO effective Oct 27, 2023
--------------------------------------------------------------------------------

- Marshall H. Woodworth appointed Acting CFO, Principal Financial and Principal Accounting Officer, effective October 27, 2023.
- Woodworth previously served as CFO of Nevakar Inc. (2017-2023), Braeburn Pharmaceuticals, and Furiex Pharmaceuticals.
- Compensation: $375 per hour paid to WhiteCap Search Holdings LLC under an engagement agreement; no family relationships or material interests.
- Woodworth entered a Proprietary Information and Invention Assignment Agreement with NeuroBo; no other arrangements in connection with appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638287/000155837023016982/0001558370-23-016982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638287/000155837023016982/nrbo-20231025x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-016982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer